Literature DB >> 12034501

Gene structure, tissue expression, and linkage mapping of the mouse DLC-1 gene (Arhgap7).

Marian E Durkin1, Bao-Zhu Yuan, Snorri S Thorgeirsson, Nicholas C Popescu.   

Abstract

DLC-1 (deleted in liver cancer 1) is a candidate tumor suppressor gene for hepatocellular carcinoma and other cancers. It is the human homologue of rat p122, which has been shown to function as a GTPase activating protein for RhoA, and it may be involved in signal transduction pathways regulating cell proliferation and adhesion. To establish an animal model for studying the regulation and function of DLC-1, we have undertaken the characterization of the mouse DLC-1 gene. Northern blot analysis shows that the mouse DLC-1 mRNA is widely expressed, with the highest levels in heart, liver, and lung. Mouse genomic clones that contain the entire DLC-1 gene of 47 kb were isolated. The mouse gene consists of 14 exons, and the structural organization is highly similar to that of the human gene. The promoter region of the mouse gene was GC-rich and contained potential binding sites for transcription factors SP1, GCF, and AP-2. A polymorphic microsatellite marker in intron 8 was used for mapping the gene (Arhgap7) to 20 cM on mouse chromosome 8 and for allelotyping of mouse liver tumor DNAs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12034501     DOI: 10.1016/s0378-1119(02)00462-6

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  11 in total

1.  Epigenetic regulation of WNT signaling in chronic lymphocytic leukemia.

Authors:  Lynda B Bennett; Kristen H Taylor; Gerald L Arthur; Farahnaz B Rahmatpanah; Sam I Hooshmand; Charles W Caldwell
Journal:  Epigenomics       Date:  2010-02-01       Impact factor: 4.778

2.  DLC2 modulates angiogenic responses in vascular endothelial cells by regulating cell attachment and migration.

Authors:  Y Lin; N-T Chen; Y-P Shih; Y-C Liao; L Xue; S H Lo
Journal:  Oncogene       Date:  2010-03-08       Impact factor: 9.867

3.  Identification and characterization of Dlc1 isoforms in the mouse and study of the biological function of a single gene trapped isoform.

Authors:  Mohammad G Sabbir; Nichola Wigle; Shauna Loewen; Yuan Gu; Cordula Buse; Geoffrey G Hicks; Michael R A Mowat
Journal:  BMC Biol       Date:  2010-03-03       Impact factor: 7.431

Review 4.  Deleted in liver cancer-1 (DLC-1): a tumor suppressor not just for liver.

Authors:  Yi-Chun Liao; Su Hao Lo
Journal:  Int J Biochem Cell Biol       Date:  2007-04-20       Impact factor: 5.085

5.  Frequent Downregulation and Promoter Hypermethylation of DLC1: Relationship with Clinical Outcome in Gallbladder Cancer.

Authors:  Deepika Singh; Amisha Bharti; Dipanjan Biswas; Mallika Tewari; Amrita Ghosh Kar; Mumtaz Ahmed Ansari; Sunita Singh; Gopeshwar Narayan
Journal:  J Gastrointest Cancer       Date:  2021-01-08

6.  Differential expression of breast cancer-associated genes between stage- and age-matched tumor specimens from African- and Caucasian-American Women diagnosed with breast cancer.

Authors:  Jessica M Grunda; Adam D Steg; Qinghua He; Mark R Steciuk; Suzanne Byan-Parker; Martin R Johnson; William E Grizzle
Journal:  BMC Res Notes       Date:  2012-05-22

7.  The role of Dlc1 isoform 2 in K-Ras2(G12D) induced thymic cancer.

Authors:  Mohammad Golam Sabbir; Heather Prieditis; Esther Ravinsky; Michael R A Mowat
Journal:  PLoS One       Date:  2012-07-05       Impact factor: 3.240

Review 8.  DLC-1:a Rho GTPase-activating protein and tumour suppressor.

Authors:  Marian E Durkin; Bao-Zhu Yuan; Xiaoling Zhou; Drazen B Zimonjic; Douglas R Lowy; Snorri S Thorgeirsson; Nicholas C Popescu
Journal:  J Cell Mol Med       Date:  2007 Sep-Oct       Impact factor: 5.310

9.  Expression of deleted in liver cancer 1 and plasminogen activator inhibitor 1 protein in ovarian carcinoma and their clinical significance.

Authors:  Fang Ren; Huirong Shi; Gong Zhang; Ruitao Zhang
Journal:  J Exp Clin Cancer Res       Date:  2013-08-30

10.  Dlc1 interaction with non-muscle myosin heavy chain II-A (Myh9) and Rac1 activation.

Authors:  Mohammad G Sabbir; Rachelle Dillon; Michael R A Mowat
Journal:  Biol Open       Date:  2016-04-15       Impact factor: 2.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.